EVLO (Evelo Biosciences) Accounts Payable: $0.53 Mil (As of Sep. 2023)


What is Evelo Biosciences Accounts Payable?

Evelo Biosciences EVLO -99.00% Accounts Payable is $0.53 Mil as of Sep. 2023.

Evelo Biosciences's Accounts Payable for the quarter that ended in Sep. 2023 was $0.53 Mil.

Evelo Biosciences's quarterly Accounts Payable increased from Mar. 2023 ($1.51 Mil) to Jun. 2023 ($3.77 Mil) but then declined from Jun. 2023 ($3.77 Mil) to Sep. 2023 ($0.53 Mil).

Evelo Biosciences's annual Accounts Payable increased from Dec. 2020 ($1.44 Mil) to Dec. 2021 ($1.60 Mil) and increased from Dec. 2021 ($1.60 Mil) to Dec. 2022 ($1.76 Mil).

Evelo Biosciences Accounts Payable Related Terms

Evelo Biosciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Evelo Biosciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evelo Biosciences Accounts Payable Chart

Evelo Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Accounts Payable
Get a 7-Day Free Trial 1.52 0.62 1.44 1.60 1.76

Evelo Biosciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.55 1.76 1.51 3.77 0.53

Evelo Biosciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.53 Mil mean?
Evelo Biosciences (EVLO) has a Accounts Payable of $0.53 Mil as of Sep. 2023. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Evelo Biosciences and its competitors.
Is Evelo Biosciences' Accounts Payable too high?
Evelo Biosciences' current Accounts Payable is $0.53 Mil.
How does Evelo Biosciences' Accounts Payable compare to IMNN and EDSA?
Evelo Biosciences' Accounts Payable of $0.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Evelo Biosciences and its competitors. Evelo Biosciences's current Accounts Payable is $0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current Accounts Payable of $0.53 Mil. The current Accounts Payable is $0.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current Accounts Payable is $0.53 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.